Clotblog with Dr Samuel GoldhaberView all posts »
Can we omit aspirin when anticoagulated patients undergo PCI?Mar 1, 2013 08:30 EST
The WOEST study—which was presented at ESC 2012 and has been published in the Lancet—provides valuable clinical-trial data to the debate on double vs triple therapy in anticoagulated patients undergoing PCI. It's a thought-provoking study. Is it time to act on the results?
Dewilde WJM, Verheugt FWA, Kelder JC, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial. Lancet 2013; epub ahead of print. Abstract.